RAS oncogenes: the first 30 years
Top Cited Papers
- 1 June 2003
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 3 (6) , 459-465
- https://doi.org/10.1038/nrc1097
Abstract
From the pioneering work with acute transforming retroviruses to the current post-genomic era, RAS genes have always been at the leading edge of signal transduction and molecular oncology. Yet, a complete understanding of RAS function and dysfunction - mainly in human cancer - is still to come. The knowledge that has accumulated since their discovery 30 years ago has, however, been remarkable, and should pave the way for not only solving the outstanding issues regarding RAS biology, but also for developing efficacious drugs that could have a significant impact on cancer treatment.Keywords
This publication has 119 references indexed in Scilit:
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras MutantsScience, 1997
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- Crystal structures at 2.2 Å resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDPJournal of Molecular Biology, 1991
- Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysisNature, 1990
- Three-Dimensional Structure of an Oncogene Protein: Catalytic Domain of Human c-H- ras P21Science, 1988
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987
- Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutationsNature, 1983
- An Unidentified Virus which causes the Rapid Production of Tumours in MiceNature, 1964